ETHERO (ALENT.PA) Fundamental Analysis & Valuation

EPA:ALENT • FR0010424697

Current stock price

1.02 EUR
-0.07 (-6.42%)
Last:

This ALENT.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ALENT.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALENT was profitable.
  • Of the past 5 years ALENT 4 years were profitable.
  • In multiple years ALENT reported negative operating cash flow during the last 5 years.
ALENT.PA Yearly Net Income VS EBIT VS OCF VS FCFALENT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500K -1M -1.5M

1.2 Ratios

  • ALENT has a Return On Assets (1.84%) which is comparable to the rest of the industry.
  • ALENT has a Return On Invested Capital of 14.66%. This is comparable to the rest of the industry: ALENT outperforms 59.09% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ALENT is significantly below the industry average of 88.57%.
  • The 3 year average ROIC (82.53%) for ALENT is well above the current ROIC(14.66%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.84%
ROE N/A
ROIC 14.66%
ROA(3y)5.37%
ROA(5y)19.39%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)82.53%
ROIC(5y)N/A
ALENT.PA Yearly ROA, ROE, ROICALENT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

  • ALENT has a Profit Margin of 8.45%. This is comparable to the rest of the industry: ALENT outperforms 50.00% of its industry peers.
  • ALENT's Profit Margin has improved in the last couple of years.
  • The Operating Margin of ALENT (14.26%) is comparable to the rest of the industry.
  • ALENT's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.26%
PM (TTM) 8.45%
GM N/A
OM growth 3Y-5.86%
OM growth 5YN/A
PM growth 3Y-11.77%
PM growth 5Y33.49%
GM growth 3YN/A
GM growth 5YN/A
ALENT.PA Yearly Profit, Operating, Gross MarginsALENT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ALENT.PA Health Analysis

2.1 Basic Checks

  • ALENT has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for ALENT remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for ALENT remains at a similar level compared to 5 years ago.
  • ALENT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ALENT.PA Yearly Shares OutstandingALENT.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALENT.PA Yearly Total Debt VS Total AssetsALENT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

2.2 Solvency

  • Based on the Altman-Z score of -0.81, we must say that ALENT is in the distress zone and has some risk of bankruptcy.
  • ALENT has a Altman-Z score of -0.81. This is in the lower half of the industry: ALENT underperforms 77.27% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.81
ROIC/WACC1.82
WACC8.04%
ALENT.PA Yearly LT Debt VS Equity VS FCFALENT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500K -500K -1M -1.5M

2.3 Liquidity

  • ALENT has a Current Ratio of 1.18. This is a normal value and indicates that ALENT is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of ALENT (1.18) is worse than 63.64% of its industry peers.
  • ALENT has a Quick Ratio of 1.18. This is a normal value and indicates that ALENT is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of ALENT (1.18) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.18
ALENT.PA Yearly Current Assets VS Current LiabilitesALENT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ALENT.PA Growth Analysis

3.1 Past

  • ALENT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 144.82%, which is quite impressive.
  • The Earnings Per Share has been growing by 40.85% on average over the past years. This is a very strong growth
  • The Revenue for ALENT has decreased by -23.68% in the past year. This is quite bad
  • ALENT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.57% yearly.
EPS 1Y (TTM)144.82%
EPS 3Y-23.13%
EPS 5Y40.85%
EPS Q2Q%-120.9%
Revenue 1Y (TTM)-23.68%
Revenue growth 3Y-12.89%
Revenue growth 5Y5.57%
Sales Q2Q%-18.04%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALENT.PA Yearly Revenue VS EstimatesALENT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

More info and screens

Find the best growth stocksShow best growing peers

1

4. ALENT.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 102.00, ALENT can be considered very expensive at the moment.
  • 63.64% of the companies in the same industry are cheaper than ALENT, based on the Price/Earnings ratio.
  • ALENT's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.61.
Industry RankSector Rank
PE 102
Fwd PE N/A
ALENT.PA Price Earnings VS Forward Price EarningsALENT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • 63.64% of the companies in the same industry are more expensive than ALENT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.16
ALENT.PA Per share dataALENT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)2.5
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALENT.PA Dividend Analysis

5.1 Amount

  • ALENT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALENT.PA Fundamentals: All Metrics, Ratios and Statistics

ETHERO

EPA:ALENT (3/25/2026, 7:00:00 PM)

1.02

-0.07 (-6.42%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.92M
Revenue(TTM)558.40K
Net Income(TTM)47.20K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 102
Fwd PE N/A
P/S 7.01
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 18.16
EPS(TTM)0.01
EY0.98%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.15
BVpS-0.01
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)2.5
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.84%
ROE N/A
ROCE 19.94%
ROIC 14.66%
ROICexc N/A
ROICexgc N/A
OM 14.26%
PM (TTM) 8.45%
GM N/A
FCFM N/A
ROA(3y)5.37%
ROA(5y)19.39%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)82.53%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)112.29%
ROCE(5y)166.87%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-5.86%
OM growth 5YN/A
PM growth 3Y-11.77%
PM growth 5Y33.49%
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.18
Quick Ratio 1.18
Altman-Z -0.81
F-ScoreN/A
WACC8.04%
ROIC/WACC1.82
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)144.82%
EPS 3Y-23.13%
EPS 5Y40.85%
EPS Q2Q%-120.9%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-23.68%
Revenue growth 3Y-12.89%
Revenue growth 5Y5.57%
Sales Q2Q%-18.04%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-58.54%
EBIT growth 3Y-18%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y110.31%
FCF growth 3Y-17.99%
FCF growth 5YN/A
OCF growth 1Y111.62%
OCF growth 3Y-17.82%
OCF growth 5YN/A

ETHERO / ALENT.PA Fundamental Analysis FAQ

What is the fundamental rating for ALENT stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALENT.PA.


Can you provide the valuation status for ETHERO?

ChartMill assigns a valuation rating of 0 / 10 to ETHERO (ALENT.PA). This can be considered as Overvalued.


Can you provide the profitability details for ETHERO?

ETHERO (ALENT.PA) has a profitability rating of 3 / 10.


What are the PE and PB ratios of ETHERO (ALENT.PA) stock?

The Price/Earnings (PE) ratio for ETHERO (ALENT.PA) is 102 and the Price/Book (PB) ratio is -110.33.